Centene (CNC)
(Delayed Data from NYSE)
$74.63 USD
-2.70 (-3.49%)
Updated May 24, 2024 04:00 PM ET
After-Market: $74.63 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth B Momentum A VGM
Centene (CNC) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$89.27 | $110.00 | $76.00 | 15.44% |
Price Target
Based on short-term price targets offered by 15 analysts, the average price target for Centene comes to $89.27. The forecasts range from a low of $76.00 to a high of $110.00. The average price target represents an increase of 15.44% from the last closing price of $77.33.
Analyst Price Targets (15)
Broker Rating
Centene currently has an average brokerage recommendation (ABR) of 1.94 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 17 brokerage firms. The current ABR compares to an ABR of 1.94 a month ago based on 17 recommendations.
Of the 17 recommendations deriving the current ABR, nine are Strong Buy, representing 52.94% of all recommendations. A month ago, Strong Buy represented 52.94%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 9 | 9 | 9 | 9 | 10 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 8 | 8 | 8 | 8 | 7 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.94 | 1.94 | 1.94 | 1.94 | 1.82 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
4/15/2024 | Truist Securities | David S Macdonald | Strong Buy | Strong Buy |
4/4/2024 | Cantor Fitzgerald & Co | Sarah James | Strong Buy | Strong Buy |
3/21/2024 | Stephens | Scott Fidel | Strong Buy | Hold |
1/29/2024 | Mizuho SecuritiesUSA | Ann K Hynes | Hold | Hold |
10/24/2023 | Argus Research Corp. | John D Staszak | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.94 |
ABR (Last week) | 1.94 |
# of Recs in ABR | 17 |
Average Target Price | $89.27 |
LT Growth Rate | 11.40% |
Industry | Medical - HMOs |
Industry Rank by ABR | 68 of 252 |
Current Quarter EPS Est: | 1.95 |